NCT02022202 2025-09-03
BEAUTY
Mayo Clinic
Completed
Clinical Trials
19 trialsNCT04648904 2025-05-22
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06283511 2025-02-28
Evaluation of the RESTART Survival Programme
Jules Bordet Institute
Not yet recruiting
NCT02802553 2024-08-27
Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions
Case Comprehensive Cancer Center
Phase NA Active not recruiting
NCT06357338 2024-04-10
Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma
Sohag University
Enrolling by invitation
NCT03595592 2024-03-06
APTneo
Fondazione Michelangelo
Phase 3 Active not recruiting
NCT03564782 2024-02-08
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer
Istari Oncology, Inc.
Phase EARLY_PHASE1 Completed
NCT01717131 2024-01-11
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
Institut Paoli-Calmettes
Phase NA Active not recruiting
NCT03709186 2023-04-11
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
Sunnybrook Health Sciences Centre
Completed
NCT05767931 2023-03-14
Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer
Peking University
Unknown
NCT01765049 2022-10-18
DEAR
Seoul National University Hospital
Unknown
NCT03630913 2022-04-22
GANEA3
Institut Cancerologie de l'Ouest
Phase NA Unknown
NCT01004744 2021-01-11
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
Columbia University
Phase NA Completed
NCT04004559 2020-06-29
RBC-02
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT03247478 2019-09-06
CTREP
Peking University
Completed
NCT02244580 2016-11-07
Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"
BioNTech Diagnostics GmbH
Phase NA Completed
NCT00486668 2016-06-06
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT01597999 2013-01-23
Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer
Mahidol University
Phase 4 Unknown
NCT00507611 2012-09-25
Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients
Ohio State University Comprehensive Cancer Center
Phase NA Completed